The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lamisil Once 1% cutaneous solution

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/121/003

Main Information

Trade NameLamisil Once 1% cutaneous solution
Active SubstancesTerbinafine
Dosage FormCutaneous solution
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/121/003

Group Information

ATC CodeD01AE Other antifungals for topical use
D01AE15 terbinafine


License statusAuthorised
Licence Issued29/09/2006
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back